SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

TTK Healthcare jumps on commissioning Fen Make Pellet manufacturing line

26 Jun 2012 Evaluate

TTK Healthcare is currently trading at Rs. 361.90, up by 15.10 points or 4.35% from its previous closing of Rs. 346.80 on the BSE.

The scrip opened at Rs. 354.95 and has touched a high and low of Rs. 361.90 and Rs. 354.95 respectively.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 680.70 on 22-Jul-2011 and a 52 week low of Rs. 330.35 on 16-May-2012.

Last one week high and low of the scrip stood at Rs. 361.90 and Rs. 337.00 respectively. The current market cap of the company is Rs. 281.00 crore.

The promoters holding in the company stood at 65.43% while Institutions and Non-Institutions held 0.11% and 34.46% respectively.

TTK Healthcare has commissioned the Fen Make Pellet (Pappad) manufacturing line and has just started commercial production at its foods division factory located at Hosakote near Bangalore. The above manufacturing line was acquired by the company from Ahmedabad based McFills Enterprises.

TTK Healthcare brand wagon consists of products that are sought after by a wide range of customers. It has an all India sales and distribution network for marketing not only their own products, but also the KIWI Brand (Shoecare), Brylcreem (Haircare) and Kohinoor and Durex brands (Contraceptives).

TTK Healthcare Share Price

930.00 -0.90 (-0.10%)
22-Apr-2026 09:36 View Price Chart
Peers
Company Name CMP
Grasim Industries 2769.30
DCM Shriram 1208.15
3M India 32027.65
Hindustan Foods 498.55
Balmer Lawrie & Co 178.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×